As it moves closer to listing its stock on the TSX Venture Exchange, Appili Therapeutics of Halifax has raised an additional $3.6 million by selling shares and warrants through a private placement.
The drug discovery company issued a statement Monday saying it had raised gross proceeds of about $3.6 million through the placement, though the total is lowered somewhat by fees paid to the banks that sold the securities.
Appili said last year it was planning to list its stock publicly, and Monday’s announcement included the news that it has filed its preliminary prospectus with six Canadian